The Billion-Dollar Molecule
Barry Werth
Engels | 01-03-1995 | 464 pagina's
9780671510572
Paperback / softback
Bekijk inkijkexemplaar
€ 22,95
Ruilen mogelijk binnen de 14 dagen (niet op specifieke bestellingen)
Gratis leveren aan huis in Sint-Niklaas
Korte beschrijving/Annotatie
Join journalist Barry Werth as he unveils the intense drama at Vertex, a start-up pharma company, focused on pioneering drug research for immunosuppressants and AIDS.
Tekst achterflap
Join journalist Barry Werth as he pulls back the curtain on Vertex, a start-up pharmaceutical company, and witness firsthand the intense drama being played out in the pioneering and hugely profitable field of drug research.
Founded by Joshua Boger, a dynamic Harvard- and Merck-trained scientific whiz kid, Vertex is dedicated to designing—atom by atom—both a new life-saving immunosuppressant drug, and a drug to combat the virus that causes AIDS.
You will be hooked from start to finish, as you go from the labs, where obsessive, fiercely competitive scientists struggle for a breakthrough, to Wall Street, where the wheeling and dealing takes on a life of its own, as Boger courts investors and finally decides to take Vertex public. Here is a fascinating no-holds-barred account of the business of science, which includes an updated epilogue about the most recent developments in the quest for a drug to cure AIDS.
Beschrijving
Join journalist Barry Werth as he pulls back the curtain on Vertex, a start-up pharmaceutical company, and witness firsthand the intense drama being played out in the pioneering and hugely profitable field of drug research.
Founded by Joshua Boger, a dynamic Harvard- and Merck-trained scientific whiz kid, Vertex is dedicated to designing—atom by atom—both a new life-saving immunosuppressant drug, and a drug to combat the virus that causes AIDS.
You will be hooked from start to finish, as you go from the labs, where obsessive, fiercely competitive scientists struggle for a breakthrough, to Wall Street, where the wheeling and dealing takes on a life of its own, as Boger courts investors and finally decides to take Vertex public. Here is a fascinating no-holds-barred account of the business of science, which includes an updated epilogue about the most recent developments in the quest for a drug to cure AIDS.
Details
EAN : | 9780671510572 |
Uitgever : | Simon & Schuster Nederland B.V. |
Publicatie datum : | 01-03-1995 |
Uitvoering : | Paperback / softback |
Taal/Talen : | Engels |
Hoogte : | 216 mm |
Breedte : | 140 mm |
Dikte : | 32 mm |
Gewicht : | 377 gr |
Status : | Bestelbaar |
Aantal pagina's : | 464 |
Reeks : | Touchstone Book |